These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21408091)

  • 21. MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.
    Hernández-Sánchez M; Rodríguez-Vicente AE; Hernández JÁ; Lumbreras E; Sarasquete ME; Martín AÁ; Benito R; Vicente-Gutiérrez C; Robledo C; Heras Nde L; Rodríguez JN; Alcoceba M; Coca AG; Aguilar C; González M; Hernández-Rivas JM
    Leuk Res; 2016 Jul; 46():30-6. PubMed ID: 27111859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia.
    Mraz M; Kipps TJ
    Leuk Lymphoma; 2013 Aug; 54(8):1836-9. PubMed ID: 23597135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is miR-29 an oncogene or tumor suppressor in CLL?
    Pekarsky Y; Croce CM
    Oncotarget; 2010 Jul; 1(3):224-7. PubMed ID: 20936047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations.
    Liu P; Wang K; Li J; Ogasawara MA; Xia Z; Wierda WG; Keating MJ; Li Y; Huang P
    Haematologica; 2024 Feb; 109(2):479-492. PubMed ID: 37646669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia.
    Kminkova J; Mraz M; Zaprazna K; Navrkalova V; Tichy B; Plevova K; Malcikova J; Cerna K; Rausch T; Benes V; Brychtova Y; Doubek M; Mayer J; Pospisilova S
    Carcinogenesis; 2014 May; 35(5):992-1002. PubMed ID: 24306027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
    Calin GA; Ferracin M; Cimmino A; Di Leva G; Shimizu M; Wojcik SE; Iorio MV; Visone R; Sever NI; Fabbri M; Iuliano R; Palumbo T; Pichiorri F; Roldo C; Garzon R; Sevignani C; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
    N Engl J Med; 2005 Oct; 353(17):1793-801. PubMed ID: 16251535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.
    Filip AA; Grenda A; Popek S; Koczkodaj D; Michalak-Wojnowska M; Budzyński M; Wąsik-Szczepanek E; Zmorzyński S; Karczmarczyk A; Giannopoulos K
    Ann Hematol; 2017 Jan; 96(1):33-50. PubMed ID: 27730344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.
    Visone R; Veronese A; Balatti V; Croce CM
    Oncotarget; 2012 Feb; 3(2):195-202. PubMed ID: 22350310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.
    Mraz M; Pospisilova S; Malinova K; Slapak I; Mayer J
    Leuk Lymphoma; 2009 Mar; 50(3):506-9. PubMed ID: 19347736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia.
    Zanette DL; Rivadavia F; Molfetta GA; Barbuzano FG; Proto-Siqueira R; Silva WA; Falcão RP; Zago MA
    Braz J Med Biol Res; 2007 Nov; 40(11):1435-40. PubMed ID: 17934639
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Balatti V; Tomasello L; Rassenti LZ; Veneziano D; Nigita G; Wang HY; Thorson JA; Kipps TJ; Pekarsky Y; Croce CM
    Blood; 2018 Nov; 132(20):2179-2182. PubMed ID: 30242085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations.
    Grenda A; Filip AA; Wąsik-Szczepanek E
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34981813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
    Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
    Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.
    Ronchetti D; Manzoni M; Agnelli L; Vinci C; Fabris S; Cutrona G; Matis S; Colombo M; Galletti S; Taiana E; Recchia AG; Bossio S; Gentile M; Musolino C; Di Raimondo F; Grilli A; Bicciato S; Cortelezzi A; Tassone P; Morabito F; Ferrarini M; Neri A
    Blood Cancer J; 2016 Sep; 6(9):e468. PubMed ID: 27611921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia.
    Rossi M; Fuligni F; Ciccone M; Agostinelli C; Righi S; Luciani M; Laginestra MA; Rigolin GM; Sapienza MR; Gazzola A; Mannu C; Cuneo A; Pileri S; Piccaluga PP
    Biomed Res Int; 2013; 2013():715391. PubMed ID: 24392455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
    Van Roosbroeck K; Calin GA
    Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
    Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
    Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.
    Guinn D; Lehman A; Fabian C; Yu L; Maddocks K; Andritsos LA; Jones JA; Flynn JM; Jaglowski SM; Woyach JA; Byrd JC; Johnson AJ
    Cancer Med; 2017 Apr; 6(4):778-787. PubMed ID: 28299881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.